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A penicillin-resistant (Penr) non-penicillinase-producing Neisseria gonorrhoeae strain responsible for an
outbreak affecting 199 persons in Durham, N.C., in 1983 was studied to' determine the genetic basis of its
unusually high-level (MIC, 2.0 ,ug/ml) Pear. Plasmid screening of the strain revealed no plasmids other than
the'2.6-megadalton cryptic plasmid. Penr was found to be partially due to mutations genotypically and
phenotypically similar to the previously characterized chromosomal loci penA, mtr, and penB. Resistance loci
from the epidemic donor strain were transformed into susceptible recipients FA19 and F62 in a stepwise
fashion; the combination of the three loci resulted in moderate levels of penicillin resistance (MIC, 0.5 ,Lg/ml),
but donor levels of resistance were not obtainable in either recipient, for uncertain reasons. Occurrence of an
antibiotic-susceptible (env) mutation in a clinical isolate of the Penr epidemic strain also was documented.
A relatively large outbreak (199 cases) of non-penicil-
linase-producing penicillin-resistant (Pen9 gonococci oc-
curred in Durham, N.C., in 1983 (3, 7). The resistant isolates
were unusual in that they did not produce detectable beta-
lactamase and yet showed relatively high resistance to
penicillin (MIC, 2 to 4 ,g/ml). Patients infected with this
strain nearly always failed therapy with penicillin G (7) or
tetracycline (unpublished data). Epidemiologic analysis of
resistant isolates by using auxotyping, serotyping, and anti-
biotic susceptibility profiles indicated that they all belonged
to a single strain of Neisseria gonorrhoeae. The strain was
relatively resistant to erythromycin (MIC, 2.0 ,g/ml) and
tetracycline (MIC, 4.0 ,tg/ml) in addition to penicillin but
was spectinomycin and streptomycin susceptible. Such iso-
lates are relatively common in the Far East but rare in the
United States (1).
The genetics and biochemistry of chromosomally medi-
ated, low-level resistance of gonococci to penicillin and
tetracycline has been studied extensively (5, 9, 13, 19, 22,
26). However, the Durham epidemic strain was more resist-
ant to penicillin than any of the previously studied isolates,
and it seemed possible that a novel genetic basis for resist-
ance might account for its high levels of resistance. Previ-
ously studied resistant strains such as FA5 were reported to
have an MIC (penicillin) of 2.0 ,ug/ml (22), but by present
tests have an MIC (penicillin) of between 0.5 and 1.0 ,g/ml
(unpublished data). In this paper, we elucidate the genetics
of resistance in this recent epidemic strain and compare it
with previously studied chromosomally resistant gonococci.
(A preliminary report of some of these results appeared
previously [8].)
MATERIALS AND METHODS
Media and culture techniques were as described previ-
ously (19). Gonococcal strains used in this study are listed in
Table 1. Auxotyping of the epidemic strain (FA6140) and
selected penicillin-susceptible isolates from Durham, N.C.,
was performed by the method of LaScolea and Young (11).
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The coagglutination technique with outer membrane protein
I (P.I) monoclonal antibodies (24) was used to serotype all
strains in this study. MICs of selected antibiotics were
determined by an agar dilution procedure as described
previously (22). Transformation experiments were carried
out with DNA prepared by the Marmur method (15). Piliated
recipients were transformed with limiting concentrations of
DNA ('0.1 ,ug/ml) by methods described earlier (19, 20).
Phenotypic levels of resistance are indicated when appropri-
ate with a number in parentheses, indicating MIC (micro-
grams per milliliter) for the strain. Thus Penr (0.5) indicates
ap MIC of penicillin of 0.5 Lg/ml.
Outer membrane preparations. Cells suspended in 10 mM
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH
7.4) (HEPES buffer) were ruptured by two passages through
a cold French pressure cell at 16,000 lb/in2. After one 10-min
centrifugation at 5,000 x g, the clear supernatant was
centrifuged at 100,000 x g for 1 h. The pellet was washed
one time by suspension and centrifugation at 100,000 x g for
1 h. The final pellet represented total membranes from which
outer membranes were isolated by selectively solubilizing
cytoplasmic membranes with 0.2% sodium lauryl sarcosin-
ate detergent (Sarkosyl) essentially as described by Walstad
et al. (25). Protein concentrations of membrane fractions
were determined by the Lowry method (12), with bovine
serum albumin as the standard. Outer membrane samples
containing 20 ,g of protein were subjected to sodium dode-
cyl sulfate-polyacrylamide gel electrophoresis on a 10%
polyacrylamide gel by the method of Laemmli (10). Proteins
were visualized by staining with Coomassie blue (23).
Plasmid analysis. Epidemic isolates were screened for
their plasmid content by the method of Meyers et al (16).
Penicillin-resistant isolates were also checked for beta-
lactamase production by the chromogenic cephalosporin
(nitrocefin; Glaxo Pharmaceuticals, Ltd., Greenford, United
Kingdom) assay (17).
RESULTS
Several resistant isolates from the Durham epidemic (7)
were screened for their plasmid content and revealed no
plasmids other than the 2.6-megadalton cryptic plasmid (18).
Beta-lactamase production was not detected in any of the
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TABLE 1. N. gonorrhoeae strains used
Strain Description
FA19... Antibiotic-susceptible wild type (14)
F62... Antibiotic-susceptible wild type (14)
FA913... Spcr Str' tran$formant of FA19
FA6140... Durham Penr epidemic strain
FA6141... FA6140 x FA19 first-step Penr (penA4)
transformant
FA6142....FA6140 x FA6141 second-step Penr
(penA4 mtr4) transformant
FA6143... FA6140 x FA6142 third-step Penr (penA4
mtr4 penB5) transformant
FA6144... FA6140 x FA6143 Tetr (penA4 mtr4
penB5 tet4) transformant
FA6145... FA6140 x FA19 Ery' (mtr4) transformant
FA6146... Spontaneous clinical env-12 mutant of
FA6140
FA6147... Nalr mutant of FA6146
FA6148... FA19 x FA6146 Eryr (env') transformant




FA963... Nalr env-J (21)
FA102... FA19 penA2 (22)
FA140... FA19 penA2 mtr-2 penB2 (22)
FA171... FA19 mtr-2 (22)
epidemic isolates. This indicated that resistance in the epi-
demic strain FA6140 probably was due to chromosomal
mutations, although the methods used might not have de-
tected very large plasmids. DNA from the Penr (2.0) donor
strain FA6140 was used to transform a laboratory strain
FA19 (MIC of penicillin, -0.015 ,ug/ml) to higher levels of
resistance. In three sequential transformations, FA19 as-
sumed increasing levels of resistance, from an initial MIC (of
penicillin) of 0.015 ,ug/ml to 0.5 ,g/ml (strains FA6141, -6142,
and -6143, respectively; Table 2). The levels of Penr at each
transformation step, and resistance to erythromycin, tetra-
cycline, and other antimicrobial agents at the second and
third Pen'r transformation steps, were nearly ideptical phe-
TABLE 2. Polygenic, additive inheritance of low-level antibiotic




FA19 0.015 s0.25 s0.25 P.IA-1
FA6140 2.0 4.0 2.0 P.IB-1
FA6141b 0.12 <0.25 s0.25 P.IA-1
FA6142C 0.25 1.0 2.0 P.A-l
FA6143d 0.5 2.0 2.0 P.IB-1
FA6144e 0.5 4.0 2.0 P.IB-1
FA6145f 0.03 1.0 2.0 P.IA-1
FA62179 s0.015 1.0 .0.25 P.IA-1
a Pen, Penicillin; Tet, tetracycline; Ery, erythromycin.
b First-step Penr transformant (FA6140 x FA19) selected with 0.03 ,ug of
penicillin per ml.
c Second-step Penr transformant (FA6140 x FA6141) selected with 0.5 jig
of erythromycin per ml.
d Third-step Penr transformant (FA6140 x FA6142) selected with 0.37 ,ug of
penicillin per ml.
e Tetr transformant (FA6140 x FA6143) selected with 2.5 p.g of tetracycline
per ml.
f Eryr transformant (FA6140 x FA19) selected with 0.5 p.g of erythromycin
per ml.
g Tetr transformant (FA6140 x FA19) selected with 0.25 ,ug tetracycline per
ml.
TABLE 3. Lack of evident recombination between the penicillin
resistance loci in FA6140 and penA2, mtr-2, and penB2
Transformants
Doutativegenorype) Recipient (genotype) to increased(putative genotype) resistancea
FA6141 (penA4) FA102 (penA2) <107b
FA6145 (mtr4) FA171 (mtr-2) <107d
FA6143 (penA4 mtr4 FA140 (penA2 mtr-2 <107d
penBS) penB2)
a Control experiments with Nalr DNA showed that the recipients were
competent: transformation frequency (proportion of exposed cells trans-
formed) to Nalr = 3 x 10-4.
b Transformants (FA6141 x FA102) were selected with 0.06 and 0.12 p.g of
penicillin per ml.
c Transformants (FA6145 x FA171) were selected with 2.0 to 3.0 ,ug of
erythromycin per ml.
d Transformants (FA6143 x FA140) were selected with 0.5 to 1.0 ,ug of
penicillin per ml.
notypically to those observed when the previously charac-
terized penA2, mtr-2, and penB2 loci were introduced into
FA19 (13, 22). Second-step transformants were selected with
equal efficiency with either penicillin or erythromycin; the
phenotype of second-step transformants was identical re-
gardless of the method of initial selection (data not shown).
To determine whether the resistance loci in FA6140 were
similar genotypically to penA, mtr, and penB, transformants
of FA19 containing resistance loci from FA6140 were
crossed against reference strains derived previously in FA19
containing the penA2, mtr-2, or penB2 markers (Table 3). In
no instance was a recombinant obtained with higher levels of
resistance. On the basis of these data, we concluded that
resistance to penicillin in FA6140 was due to the additive
effect of multiple mutations and that some of the mutations
were phenotypically and genotypically similar to previously
characterized penA, mtr, and penB loci. We designated the
respective loci in FA6140 penA4, mtr4, and penBS.
Many efforts were made to transform either FA6143 or
FA6144 or similar derivatives of F62 to donor-level (penicil-
lin MIC, -2.0 ,g/ml) penicillin resistance, using saturating
concentrations of FA6140 DNA. No such transformant was
obtained, despite using small increments of penicillin in the
selection down to a concentration that allowed the recipient
strain to grow on control plates, and despite prolonged
incubations (10 h) before addition of penicillin to plates
containing recipient cells and FA6140 DNA.
In earlier studies of outer membranes of mtr-2 and penB2
transformants, the mtr-2 locus resulted in increased amounts
of a 52-kilodalton (kDa) protein (9), and penB2 was closely
linked to loci designated nmp that affected the Mr of the
principal outer membrane P.1 (2). When outer membranes of
transformants containing mtr4 were examined, increased
amounts of an approximately 52-kDa protein were observed
(Fig. 1). In other experiments, the 52-kDa protein of FA171,
an mtr-2 derivative of FA19, migrated identically with the
52-kDa protein shown in Fig. 1 (data not shown). There was
a change in recipient outer membrane P.IA-1 serovar to the
donor P.IB-1 serovar with introduction of penBS in 119 of
120 tested transformants. Thus, by these criteria the mtr and
penB loci in FA6140 were very similar to those characterized
earlier in other somewhat less Penr strains (2, 9).
A transformant of FA6143 selected for increased tetracy-
cline resistance (Tetr) (FA6144) exhibited increased resist-
ance to tetracycline only. It was not clear whether this was
due to a locus similar to tet (18), tem (26), or another Tetr
locus. The tet locus was reported to increase resistance to
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tetracycline in the absence of other resistance loci, whereas
tem acts as a modifier of resistance mediated by other loci
but by itself does not lead to Tetr (26). Since introduction of
the Tetr locus from FA6140 into FA19 resulted in increased
Tetr (FA6217, Table 2) in the apparent absence of other
resistance markers, the Tetr locus in FA6144 was phenotyp-
ically more like the previously characterized tet-2 than tem
locus. We could not exclude the possibility that other linked
resistance markers could have been introduced with the Tetr
locus, however.
To further identify the Tetr locus, we investigated linkage
with loci for spectinomycin resistance (Spc9 or streptomycin
resistance (Str). DNA from FA6217 (Tetr Spcs Str5) was
introduced into FA913 (Tets, Spcr, Strr). Tetr transformants
were selected and scored for acquisition of Spcs or Strs from
the donor. Among Tetr transformants, 77 of 80 became Strs,
and 63 of 80 became Spcs; 61 of 80 Tetr transformants
acquired both Spcs and Strs from the donor. Although the
linkage between the Tetr locus and the spc and str loci was
considerably greater than observed in previous experiments
with DNA containing tet-2 (19), the data suggested that the
Tetr locus in FA6140 was analogous to tet-2. We designated
the Tetr locus in FA6140 tet4.
Although neither FA19 nor F62 could be transformed to
donor-level (penicillin MIC, .2.0 ,g/ml) penicillin resist-
ance, FA6146, a clinical strain isolated in Durham in 1983
during the epidemic of Penr gonococcal infections, was
readily transformed to such levels of Penr. FA6146 has MICs
of 0.25 ug of penicillin per ml, 1.0 pg of tetracycline per ml,
and <0.25 pAg of erythromycin per ml; it also has an
auxotype and serotype identical to the Penr epidemic strain
FA6140 (proline-requiring auxotroph, P.IB-1 serovar). Us-
ing limiting concentrations of donor DNA from FA6140, we
obtained single-step transformants of FA6146 with levels of
resistance equal to that seen in FA6140 at high frequency
(about 10-s).
This result was compatible with the idea that FA6140
might donate single-step Penr (2.0) only to certain recipients.
However, it also seemed plausible that FA6146 was a
single-step antibiotic-susceptible mutant of FA6140 that had
FIG. 1. Sodium dodecyl sulfate-10% polyacrylamide gel electro-
phoresis of outer membrane proteins of various strains of N.
gonorrhoeae. Lane a coptains the donor Penr strain FA6140, and
lane b contains the recipient sensitive strain FA19. Lanes c, d, e, f,
g, and h contain transformants FA6141 (penA4), FA6142 (penA4
mtr-4), FA6145 (mtr-4), FA6143 (penA4 mtr-4 penB5), FA6144
(penA4 mtr-4 penB5 tet-4), and FA6217 (tet-4), respectively. Lane i
contains the env-12 mutant FA6146, and lane j contains FA6148, an
env + transformant of FA6146. Numbers on left are molecular size in
kilodaltons.
TABLE 4. Demonstration that the env-12 locus recombines with
env-3 and env-10 but not with env-l apid env-2
Transformants Recombination
Donor DNA Recipient (per ml) index
Ery' Nal1 (EryrNair)
FA6147 (Nalr BR54 (env-3 1,700 4,400 0.39
env-12) nal +)
FA6147 (Nall BR84 (env-J 0 4,500 0
env-12) nal +)
FA6147 (Nalr BR87 (env-2 0 22,000 0
env-12) nal +)
FA%3 (Nalr FA6146 (env-12 1,550 6,500 0.24
env-10) nal +)
a Transformants were selected with 0.5 ,ug of erythromycin per ml.
bTransformants were selected with 5.0 ,ug of nalidixic acid per ml.
arisen during the 1983 epidemic in Durham; several muta-
tions designated env have been characterized that phenotyp-
ically suppress multiple chromosomal antibiotic resistance
mutations (6, 20, 21). If this were the case, donor DNA from
FA6146 should be able to transfer antibiotic resistance to
susceptible recipients such as FA19, and an antibiotic-
susceptible (env') strain such as FA19 also should be able to
transform FA6146 to multiple antibiotic resistance. Results
showed that FA6146 was able to transform FA19 to Penr
(0.5) in three steps exactly as FA6140 did and that FA6146
(erythromycin MIC, 0.25 ,g/ml) was able to transform FA19
(erythromycin MIC, 0.25 pg/ml) to Eryr (erythromycin MIC,
2.0 ,ug/ml) (data not shown). Moreover, FA19 was able to
transform FA6146 to multiple drug resistance in a single
step, and the transformants were phenotypically indistin-
guishable from FA6140 (data not shown).
These observations strongly suggested that FA6146 was
an antibiotic-susceptible mutant of FA6140, and we desig-
nated the locus for antibiotic susceptibility env-12. To fur-
ther confirm the identity of the env-12 mutation, a sponta-
neous nalidixic acid-resistant (Nalr) mutant of FA6146
(FA6147) was selected and crossed against strains with
previously characterized env mutations (20, 21). The env-12
mutation in FA6147 did not recombine with the previously
characterized env-J and env-2 mutations but did recombine
readily with env-3 and env-10 (Table 4). Thus, the env-12
mutation in FA6146 is very similar to env-J and env-2.
Outer membrane proteins of FA6140, env-12 mutant
FA6146, and FA6148, an env' transformant of FA6146, are
shown in Fig. 1. FA6140 (lane a) and mtr4 transformants of
FA19 (lanes d to g) demonstrate a prominent, approximately
52-kDa protein, as expected for strains containing mtr (9).
Lane i contains FA6146 (env-12) in which the mtr phenotype
is suppressed: the 52-kDa protein is decreased. Lane j
contains the env + transformant FA6148 and demonstrates
increased amounts of the mtr4-determined 52-kDa protein
again. These results are very similar to those demonstrated
previously for mtr-2 and env-2 (9).
DISCUSSION
Resistance to penicillin and other antibiotics in FA6140
was shown to be due to the additive effects of several
mutations. Multistep acquisition of Penr from FA6140 was
demonstrated in two susceptible recipients (FA19, F62). The
resistance loci in FA6140 were designated penA4, mtr4, and
penBS and were indistinguishable from the penA2, mtr-2,
and penB2 loci characterized a decade ago (22). Since no
unusual plasmids were found in FA6140, and since penA4,
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mtr4, and penB5 failed to recombine with loci (penA2,
mtr-2, and penB2) that are known to be chromosomal (19,
22), the resistance loci in FA6140 almost certainly are
chromosomal as well. The designation of strains such as
FA6140 as CMRNG (4) (chromosomally mediated resistance
N. gonorrhoeae) therefore is apt.
Comparison of the present results with those obtained
earlier by several laboratories with a number of presumably
unrelated slightly less resistant gonococcal isolates (5, 13,
22) reveals remarkably similar inheritance of low-level
chromosomally mediated Penr. The genetic basis for the
slightly higher Penr in FA6140 (Penr [2.0]) compared with
that of previously studied isolates (Penr [0.5 to 1.0]) proved
elusive. Despite multiple attempts, we were unable to trans-
form FA19 or F62 to levels of resistance seen in the epidemic
strain. It may be that the penA4, mtr4, and penB5 mutations
in FA6140 result in higher phenotypic levels of resistance in
certain strains owing to background differences in membrane
or cell wall structure; we may not have used the proper
recipient. It may also be that there are additional resistance
markers which have not yet been identified which either are
incompatible for some reason with the background of the
FA19 and F62 strains we used as recipients or are too
numerous and too widely separated to be transformed in a
single step.
To eliminate some of the background differences which
might have interfered with expression of the higher level of
resistance, we screened Pens isolates from Durham looking
for one with the same auxotype and serotype as the epidemic
strain. FA6146 was then selected for transformation with the
epidemic strain (FA6140) DNA. We were able to transform
FA6146 to levels of resistance identical to those of FA6140.
However, further analysis revealed that FA6146 probably
was identical to FA6140, containing very similar to identical
resistance loci but in addition an env-12 mutation. env
mutations can occur spontaneously and are responsible for
membrane permeability changes which cause nonspecific
increased susceptibility to a variety of drugs, dyes, and
detergents, overcoming the phenotypic resistance deter-
mined by mtr, penB, and possibly other loci (6, 20, 21).
It has been noticed, although we have not seen it in our
laboratory, that Penr non-penicillinase-producing gonococci
such as FA6140 occasionally lose their high level of penicil-
lin resistance on repeated subculture in vitro, with decreases
in penicillin MIC to 0.25 to 0.5 ,ug/ml (J. Biddle, personal
communication). The spontaneous acquisition of env muta-
tions may explain the phenotypic loss of resistance seen
occasionally with serial passage of these strains. FA6146
isolated from Durham during the 1983 epidemic apparently
acquired the env mutation in vivo. Membrane changes
associated with increased permeability may offer selective
advantage to relatively resistant gonococci in the absence of
selective pressures of antibiotics (6).
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